Global Health Limited
All news and filings related to Global Health Limited.
View all news & filings- Medium impact
Medanta Acquires Land in Ghaziabad for ₹165.82 Crore to Build 350+ Bed Hospital
Global Health Limited acquired a 10,560 sq. metre land parcel in Ghaziabad for ₹165.82 crore. The company plans to develop a 350+ bedded hospital on this site to expand its healthcare footprint in Uttar Pradesh and strengthen its presence in the Delhi-NCR region.
Read the summary - Medium impact
Global Health (MEDANTA) Acquires Land for New 350+ Bed Hospital in Ghaziabad for ₹165.82 Crore
Global Health Limited acquired 10,560.36 sq. meters of land in Ghaziabad for approximately ₹165.82 crore. The land will be used to construct a 350+ bed hospital, subject to board and statutory approvals. The company received the land allotment on September 28, 2026.
Read the summary - Low impact
Global Health Limited Closes Trading Window from Oct 1, 2026
Global Health Limited is closing its trading window from October 1, 2026. The window will reopen 48 hours after the declaration of unaudited financial results for the second quarter ended September 30, 2026.
Read the summary - Low impact
Medanta Schedules Investor Meeting for September 25, 2026
Global Health Limited will meet with Arohi Asset Management on September 25, 2026. The meeting will be conducted virtually and is a one-to-one interaction. No Unpublished Price Sensitive Information will be shared.
Read the summary - Low impact
Global Health Limited Allots 3,000 Equity Shares Under LTIP 2024 Plan
Global Health Limited has approved the allotment of 3,000 Equity Shares under its LTIP 2024 Plan. The shares were issued to the GHL Employee's Welfare Trust at a premium of Rs. 1,498 per share on September 22, 2026. This allotment increases the company's paid-up share capital to Rs. 53,77,49,564.
Read the summary - Low impact
Medanta Schedules Investor Meeting on September 23, 2026
Global Health Limited (Medanta) will meet with USS Investment Management Ltd on September 23, 2026, in Gurugram. This one-to-one meeting will be held in person. No Unpublished Price Sensitive Information will be shared.
Read the summary - Medium impact
Medanta's 22nd AGM Concludes: Key Resolutions Approved, Including Final Dividend
Medanta's 22nd AGM was held on September 16, 2026. Resolutions approved included the adoption of FY26 financial statements and a final dividend of ₹0.50 per equity share. The appointment of a director and remuneration for cost auditors were also approved.
Read the summary - Low impact
Global Health Limited Holds 22nd AGM on Sep 16, 2026, Approves Dividend
Global Health Limited held its 22nd AGM on September 16, 2026. The company declared a final dividend of ₹0.50 per equity share for FY 2025-26. The audited financial statements for the year ended March 31, 2026, were adopted. Mr. Pankaj Sahni was re-elected as a director.
Read the summary - Low impact
Medanta Schedules Investor Meetings with Jefferies and Kotak in September 2026
Global Health Limited (Medanta) will hold investor and analyst meetings on September 17 and September 18, 2026. The meetings are organized by Jefferies and Kotak, respectively. No Unpublished Price Sensitive Information will be shared.
Read the summary - Low impact
Global Health Limited to meet Investors/Analysts on September 15, 2026, organized by Jefferies.
Global Health Limited will hold an investor and analyst meeting on September 15, 2026, organized by Jefferies in Noida. The meeting will be in-person, and no Unpublished Price Sensitive Information will be disclosed.
Read the summary - Low impact
Global Health Limited Announces Investor Meeting on September 14, 2026
Global Health Limited will participate in an investor and analyst meeting organized by Jefferies. The meeting is scheduled for September 14, 2026, in Lucknow and will be held in person. No Unpublished Price Sensitive Information will be shared.
Read the summary - Low impact
Global Health Limited Schedules Investor Meetings in September 2026
Global Health Limited (MEDANTA) will hold investor meetings on September 10, 2026, with Polar Capital and on September 14, 2026, with Chikara Investments. These are one-to-one in-person meetings in Gurugram. No UPSI will be shared.
Read the summary - Low impact
Global Health Limited Schedules Investor Meetings on September 8, 2026
Global Health Limited will meet with investors and analysts, including Matthews International Capital Management and Baillie Gifford, on September 8, 2026. The meetings will be held in person in Gurugram. No unpublished price sensitive information will be shared.
Read the summary - Low impact
Global Health (MEDANTA) to meet Investors/Analysts on August 31, 2026
Global Health Limited (MEDANTA) will hold an investor and analyst meeting on August 31, 2026, in Noida. The meeting, organized by Prabhudas Lilladher Capital, will be in-person and include one-to-one and group sessions. No price-sensitive information will be disclosed.
Read the summary - Low impact
Global Health Limited (MEDANTA) Schedules Analyst/Investor Meetings on Aug 26-27, 2026
Global Health Limited (MEDANTA) will hold one-to-one meetings with Motilal Oswal Financial Services Limited on August 26 and August 27, 2026. These meetings will be conducted in person. No Unpublished Price Sensitive Information will be disclosed.
Read the summary - Low impact
Global Health Limited Schedules 22nd AGM for September 16, 2026
Global Health Limited (Medanta) will hold its 22nd AGM on September 16, 2026, via VC/OAVM. Annual report and AGM notice for FY25-26 dispatched on August 21, 2026. Remote e-voting available from September 12-15, 2026. Cut-off date for voting rights is September 10, 2026.
Read the summary - Low impact
Global Health Limited Announces AGM on Sep 16, 2026, with Dividend Payment by Oct 15
Global Health Limited (MEDANTA) will hold its 22nd AGM on September 16, 2026, via VC/OAVM. The company has dispatched its Annual Report for FY 2025-26. The record date for the final dividend is August 14, 2026, with payment expected by October 15, 2026.
Read the summary - Low impact
Global Health Limited Releases Business Responsibility and Sustainability Report for FY 2025-26
Global Health Limited (Medanta) has released its Business Responsibility and Sustainability Report for FY 2025-26. The report details operations across six hospitals, with a turnover of ₹4,508.86 crore and a workforce of 14,777. It highlights ESG risks and opportunities, including patient safety, waste management, and energy efficiency. Medanta is expanding renewable energy integration and transitioning to electric vehicles.
Read the summary - Medium impact
Global Health Limited Announces 22nd AGM on Sep 16, 2026, to Discuss FY26 Results & Dividend
Global Health Limited's 22nd AGM is scheduled for September 16, 2026, to approve FY26 financial statements. A final dividend of ₹0.50 per equity share is proposed. The meeting will also address director re-election and cost auditor remuneration of ₹12.50 Lakhs. Remote e-voting is available from September 12-15, 2026.
Read the summary - Low impact
Global Health Limited to meet First Ray Capital, Singapore on August 21, 2026
Global Health Limited's management will meet with First Ray Capital, Singapore on August 21, 2026, in a virtual one-to-one meeting. No unpublished price sensitive information will be shared.
Read the summary - Low impact
Global Health Limited Announces 22nd AGM on September 16, 2026
Global Health Limited will hold its 22nd Annual General Meeting on September 16, 2026, at 12 Noon IST. The meeting will be conducted via Video Conference (VC) and Other Audio Visual Means (OAVM). This announcement follows newspaper advertisements dated August 12, 2026.
Read the summary - High impact
Medanta Q1 FY27 Earnings Call Transcript Released
Medanta's Q1 FY27 results showed a 26% YoY increase in consolidated income to ₹13,262 million. EBITDA grew 23% to ₹3,153 million. Noida's EBITDA loss significantly reduced to ₹49 million. Expansion includes a 650-bed Guwahati hospital costing ₹9,700 million. The company anticipates continued demand for quality healthcare and focuses on operational efficiency and network growth.
Read the summary - Low impact
Medanta Releases Q1 FY27 Earnings Call Audio Recording
Medanta released the audio recording of its Q1 FY27 earnings conference call held on July 31, 2026. The call, hosted by JM Financial, covered financial results for the quarter ended June 30, 2026. The recording is available on the company's website.
Read the summary - Medium impact
Global Health Limited Announces Q1 FY27 Unaudited Financial Results
Global Health Limited (MEDANTA) reported Q1 FY27 unaudited results. Revenue was ₹13,040.51 million. Net profit after tax was ₹1,572.52 million. EPS stood at ₹5.91 (basic). A dividend of ₹0.40 per share was declared. The Board approved these results on July 30, 2026.
Read the summary - High impact
Medanta Q1 FY27 Total Income Rises 26.2% YoY to ₹13,262 Million
Global Health Limited reported record Q1 FY27 consolidated total income of ₹13,262 million, up 26.2% YoY. EBITDA grew 23.5% to ₹3,153 million. Patient volumes increased significantly. The company added 72 beds and plans to add 2,950 beds across five greenfield projects, including a 650-bed hospital in Guwahati.
Read the summary - High impact
Medanta Board Approves Q1 FY27 Results, Reappoints Chief Digital Officer, Expands Guwahati Hospital Plan
Medanta's Board approved Q1 FY27 results. The company announced a final dividend of ₹0.50 per share for FY26, with a record date of August 14, 2026. Mr. Pradeep Kumar Singh was appointed Chief Digital Officer. The Guwahati hospital's bed capacity will increase to 650 beds, with an estimated project cost of ₹970 crore.
Read the summary - High impact
Medanta Board Approves Q1 FY26 Results, Declares ₹0.50 Dividend, Expands Guwahati Hospital Plan
Medanta's Board approved Q1 FY26 results. A final dividend of ₹0.50 per share is proposed, with August 14, 2026, as the record date. The Guwahati hospital's capacity is increased to 650 beds with an estimated investment of ₹970 crores. Pradeep Kumar Singh was appointed Chief Digital Officer.
Read the summary - High impact
Medanta Board Approves Q1 FY27 Results, Sets Record Date for ₹0.50 Dividend, Expands Guwahati Hospital Plan
Medanta approved Q1 FY27 results and appointed Pradeep Kumar Singh as Chief Digital Officer. The company set August 14, 2026, as the record date for a ₹0.50 per share final dividend. The Guwahati hospital's capacity is increased to 650 beds with an estimated cost of ₹970 crore.
Read the summary - High impact
Medanta Approves Q1 FY27 Results, Sets AGM, Appoints Chief Digital Officer, Expands Guwahati Hospital
Global Health Limited reported its Q1 FY27 results. The company will hold its 22nd AGM on September 16, 2026, and has fixed August 14, 2026, as the record date for a ₹0.50 per share final dividend. Mr. Pradeep Kumar Singh was appointed Chief Digital Officer. Medanta is expanding its Guwahati hospital to 650 beds with an investment of ₹970 crore.
Read the summary - Low impact
Medanta Schedules Q1 FY2027 Earnings Conference Call for July 31, 2026
Global Health Limited (Medanta) will host an earnings conference call on July 31, 2026, at 2:00 PM IST to discuss Q1 FY2027 financial results. The call will feature key management personnel and will be hosted by JM Financial.
Read the summary - Low impact
Global Health Limited Files SEBI Regulation 74(5) Certificate for Q1 FY27
Global Health Limited submitted a certificate for the quarter ended June 30, 2026, under SEBI Regulation 74(5). The registrar confirmed no securities were dematerialized or rematerialized during the period, requiring no further intimation to depositories or stock exchanges. This is a routine compliance filing.
Read the summary - Low impact
Global Health Limited: Trading Window Closed from July 1, 2026, for Q1 FY27 Results
Global Health Limited will close its trading window from July 1, 2026. The window will reopen 48 hours after the declaration of the unaudited financial results for the first quarter ended June 30, 2026.
Read the summary - Low impact
Global Health Limited (MEDANTA) Schedules Investor Meetings on June 26 & June 30, 2026
Global Health Limited (MEDANTA) will hold virtual one-to-one investor meetings. Management will meet with IKIGAI Asset Manager Holdings Private Limited on June 26, 2026, and Enam Asset Management Company Private Limited on June 30, 2026. No UPSI will be shared.
Read the summary - Low impact
Global Health (Medanta) to Meet Investors on June 24-26
Global Health Limited (Medanta) will hold investor and analyst meetings from June 24-26, 2026, organized by Nuvama Institutional Equities. Meetings will be one-on-one and in-person in Noida, Gurugram, and Lucknow. No UPSI will be disclosed.
Read the summary - Low impact
Global Health Limited Schedules Investor Meetings on June 22-23, 2026
Global Health Limited (Medanta) will meet investors and analysts on June 22 in Lucknow and June 23 in Noida. The meetings are organized by Elara Securities. No price-sensitive information will be disclosed.
Read the summary - Low impact
Medanta Schedules Investor Meeting with Motilal Oswal on June 19, 2026
Global Health Limited (Medanta) will meet investors and analysts on June 19, 2026, in Noida. The meeting is organized by Motilal Oswal Financial Services Ltd. No Unpublished Price Sensitive Information will be shared.
Read the summary - Low impact
Global Health Limited (Medanta) to Meet JP Morgan and IIFL Capital Investors
Global Health Limited (Medanta) will hold investor meetings with JP Morgan on June 17, 2026, in Noida, and with IIFL Capital on June 18, 2026, in London. No unpublished price sensitive information will be shared.
Read the summary - Medium impact
Medanta receives LOI from Haryana Govt. for 150 MBBS seats at Gurugram
Global Health Limited (Medanta) received a Letter of Intent (LOI) from the Government of Haryana to establish a Medical College with 150 MBBS seats at its Gurugram facility. This aligns with the company's commitment to healthcare services and talent development.
Read the summary - Low impact
Global Health Limited to Meet Investors/Analysts on June 15, 2026
Global Health Limited's management will meet investors and analysts on June 15, 2026, in Gurugram. The one-to-one meeting, organized by Ambit Private Limited, will be conducted in person. No Unpublished Price Sensitive Information will be shared.
Read the summary - Low impact
Global Health Limited (MEDANTA) to Meet Investors in Singapore on June 9-10, 2026
Global Health Limited (MEDANTA) management will attend an Institutional Investor Meeting in Singapore on June 9-10, 2026. The meetings, organized by Kotak Institutional Equity, will include one-to-one and group sessions. No Unpublished Price Sensitive Information will be disclosed.
Read the summary - Low impact
Global Health Limited Schedules Investor Meetings from June 4, 2026
Global Health Limited (MEDANTA) will hold a virtual one-to-one meeting with Prudent Corporate Advisory Ltd on June 04, 2026. No Unpublished Price Sensitive Information will be disclosed during the meeting. This is an update on investor engagement activities.
Read the summary - Low impact
Medanta to Meet Investors/Analysts on May 27 & 28, 2026
Global Health Limited (Medanta) will hold investor and analyst meetings on May 27 and May 28, 2026. The meetings, organized by ICICI Prudential AMC Ltd. and IIFL Capital Asset Management Limited respectively, will be conducted in person in Gurugram and virtually. No price-sensitive information will be disclosed.
Read the summary - Medium impact
Global Health Limited Releases Q4 FY26 Earnings Call Transcript
Global Health Limited (Medanta) released its Q4 FY26 earnings call transcript. For FY26, total income grew 20% to ₹45,089 million, and PAT increased 15.1% to ₹5,541 million. Q4 FY26 revenue grew 25% to ₹11,958 million, with PAT up 40% to ₹1,417 million. The company plans to add ~500 beds short-term and 2,700 via greenfield projects over 3-4 years.
Read the summary - Low impact
Medanta Releases Audio Recording of Q4 FY26 Earnings Conference Call
Global Health Limited (Medanta) has released the audio recording of its earnings conference call held on May 15, 2026. The call discussed financial results for the fourth quarter and fiscal year ended March 31, 2026. The recording is available on the company's investor relations website.
Read the summary - Low impact
Global Health Limited (MEDANTA) Publishes Audited Financial Results for FY26
Global Health Limited (MEDANTA) announced its audited financial results for the quarter and financial year ended March 31, 2026. The results were published in Financial Express and Jansatta on May 15, 2026.
Read the summary - High impact
Global Health Limited (Medanta) Presents Investor Presentation for FY2026 Results
Global Health Limited (Medanta) reported FY2026 consolidated income of ₹45,089 million (up 19.6% YoY) and PAT of ₹5,541 million (up 15.1% YoY). Q4 FY2026 saw record revenue of ₹11,958 million (up 25.3% YoY). The company added 623 beds in FY2026 and plans over ₹45,000 million capex for future expansion.
Read the summary - High impact
Medanta Q4 FY26 Revenue Jumps 25.3% to ₹11,958 Million, PAT Up 39.7%
Global Health Limited (Medanta) reported FY2026 consolidated total income of ₹45,089 million, up 19.6% YoY. PAT grew 15.1% to ₹5,541 million. Q4 FY26 revenue was ₹11,958 million, up 25.3% YoY, with PAT at ₹1,417 million, up 39.7%. The board recommended a final dividend of 25% (₹0.50 per share).
Read the summary - Medium impact
Medanta Board Approves FY26 Results, Recommends Final Dividend of ₹0.50/Share
Medanta's Board approved FY26 results and recommended a final dividend of ₹0.50 per share. Mr. Kedar Ashok Apte was appointed Chief Marketing & Growth Officer, and Mr. Jagdeep Singh as General Counsel, effective May 14, 2026. Ms. Richa Singh resigned as SMP, effective May 20, 2026.
Read the summary - Low impact
Medanta Schedules Q4 FY2026 Earnings Conference Call for May 15, 2026
Global Health Limited (Medanta) will host its Q4 FY2026 earnings conference call on Friday, May 15, 2026, at 2:00 PM IST. The call, hosted by ICICI Securities, will feature key management personnel including Dr. Naresh Trehan and Mr. Pankaj Sahni.
Read the summary - Medium impact
Medanta Acquires 80-Bed Cancer Hospital in Indore for ₹30 Crore
Global Health Limited (Medanta) will acquire an 80-bed Cancer Hospital in Indore for ₹30 crore via a Business Transfer Agreement. This acquisition aims to strengthen Medanta's oncology services in Central India and complement its existing Indore facility, enhancing patient access and operational synergies.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio